March 23, 2012
“Ontario continues to take action to address the effects stemming from the drug supply interruption at Sandoz. Working with our partners in the health care system, we have put in place a plan to ensure any effect on patients is minimized.We are also closely monitoring the recent drug recall following a packaging error to determine any effects it may have and to ensure the continued delivery of care."
– Deb Matthews, Minister of Health and Long-Term Care
Sandoz produces several critical drugs that are used routinely to treat patients in hospitals and other care settings.
There have been no reported cancellations or delays of surgeries at Ontario public hospitals due to this shortage at this time.
On March 7, 2012, the Minister of Health and Long-term Care, Deb Matthews, announced a five point plan to take action to address the effects stemming from production and distribution issues. Since then, progress has been made on each of these action items.
1. Inventory and impact assessment Key to the ministry´s plan is an accurate and timely assessment of current inventory and associated impact. Risks assessment combines data on inventory, allocations from Sandoz, alternative sources and therapeutic alternatives. |
The ministry developed templates and now receives standardized daily inventory updates from hospitals and community organizations to identify areas of risk.
The ministry has requested and received a forecast from Sandoz on future drug availability. The ministry is developing a list of “drugs of most concern”, based on the advice of a Technical Advisory Group. The ministry is working with partners to find alternative procurement for high-risk drugs where no alternatives have been identified. |
2. Inventory management While therapeutic alternatives are the first course of action, there may be the need to redistribute certain drugs in order to address specific shortages. |
The ministry is working with a Technical Advisory Group to develop sources of information regarding therapeutic alternatives and Drug Information Centres for guidance on medication information. Redistribution strategies are being developed with Local Health Integration Networks (LHINs) and health providers in anticipation of redistribution, if required. |
3. Drug procurement Procurement activities are aligned with efforts across Canada and through the purchasing organizations that buy drugs for Ontario´s hospitals. |
The ministry is working with group purchasing organizations to understand their efforts on behalf of Ontario´s hospitals. The ministry is holding frequent meetings with provincial, territorial partners to secure alternative sources of medications. |
4. Service delivery plan Should it be necessary to make decisions regarding drug redistribution or prioritization of services due to drug shortages, decisions will be supported through a principled framework. |
An ethical framework has been developed, with the help of an external group of ethicists, a technical advisory group and stakeholders, to support decision-making should drug redistribution or service modification be required. This document has been circulated to health providers and stakeholder associations.
|
5. Communications Frequent communications are underway to provide information, to implement tools and plans and to learn of issues. |
|
Zita Astravas, 416-327-9728
Minister's Office
Andrew Morrison, 416-314-6197
Ministry of Health and Long-Term Care
ontario.ca/health-news
If you are a reporter with a question for a story, or with comments about how this News Room section could serve you better, send us an e-mail at: media@moh.gov.on.ca
Media Line
Toll-free: 1-888-414-4774
In Toronto: 416-314-6197
Public Inquiries
Call ServiceOntario, Infoline
at 1-866-532-3161
TTY 1-800-387-5559.
In Toronto, TTY 416-327-4282
Hours of operation : 8:30am - 5:00pm